AMT vs TCRX · P/E 31, rev $10.64B vs rev $2.0M
American Tower Corp (AMT) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the AMT and TCRX stock pages for the full models.
Not investment advice.